x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Rheumnow Podcast

Dr Jack Cush reviews the news, journal reports and regulatory decisions from the past week on RheumNow.com

health & fitness medicine

All Episodes

59:25

EULAR 2025 Rheumatology RoundUp Hosted by Dr. John J....

Rheumnow Podcast ·

2025/06/25

Join rheumatology experts Dr. John J. Cush and Dr. Arthur Kavanaugh for the EULAR Rheumatology RoundUp — a dynamic, fast-paced discussion capturing the most impactful highlights, late-breaking data, and clinical takeaways from EULAR 2025.

en

53:38

EULAR 2025 - Day 9 podcast

Rheumnow Podcast ·

2025/06/24

Trends and Innovations from Barcelona (6.20.2025)AI Advances axSpA Diagnosis with Multimodal MRI IL-17 Inhibitors in Psoriatic Arthritis IL-17 Inhibitors for Axial Spondyloarthritis New IL-17 Inhibition New Molecular Constructs

en

27:51

Trends and Innovations from Barcelona (6.20.2025)

Rheumnow Podcast ·

2025/06/20

en

40:02

EULAR 2025 - Day 8 podcast

Rheumnow Podcast ·

2025/06/20

Resilience or Resignation? Rethinking Pain, Aging, and Quality of LifeSpondyloarthritis Panel: Eular 2025

en

36:38

EULAR 2025 – SpA Panel Discussion

Rheumnow Podcast ·

2025/06/19

Leading rheumatology experts discuss the latest research, treatment advances, and clinical insights in axial spondyloarthritis. Hear what’s new from EULAR 2025 and what it means for improving patient outcomes.

en

14:45

EULAR 2025 - Day 7 podcast

Rheumnow Podcast ·

2025/06/19

Digital Behavioural Therapy for Persistent Pain in Axial SpondyloarthritisThere's an App for That (and it works): the AXIA RCT

en

01:06:57

EULAR 2025 - Day 6 podcast

Rheumnow Podcast ·

2025/06/18

Eular 2025 PsA Topic PanelAssessment of Peripheral Arthritis in Spondyloarthritis IL-17 inhibitors - Novel Drugs IL17 inhibitors - Long-term Extensions and Uveitis IL17 inhibitors - STAMP T2T and Combinations Using AI for Reading PET/CT in Rheumatoid Arthritis

en

40:37

Eular 2025 PsA Topic Panel

Rheumnow Podcast ·

2025/06/17

en

50:09

EULAR 2025 – RA Panel Discussion

Rheumnow Podcast ·

2025/06/17

Leading experts in rheumatology dive into the latest advances, treatment strategies, and emerging research in rheumatoid arthritis. Don’t miss this in-depth panel as they unpack key findings from EULAR 2025 and discuss what’s next for RA care.

en

13:20

EULAR2025 Topic Podcast IL-17

Rheumnow Podcast ·

2025/06/16

Efficacy and Safety of Xeligekimab in AS Sonelokimab in PsA Seronegative Arthritis Breakthroughs Novel Therapies in Axial Spondyloarthritis

en

29:42

EULAR2025 Topic Podcast RA2

Rheumnow Podcast ·

2025/06/16

JAK Inhibitors: The Latest from the JAK-pot Study Does Abatacept Buy You Time Off RA? How to Properly Use Steroids in Early RA: Oral vs Parenteral All Rheumatoid Arthritis is Not the Same Jekyll and Hyde: which RA-ILD is it? RA treatment: A Constant State of Evolution

en

53:37

EULAR2025 Topic Podcast RA1

Rheumnow Podcast ·

2025/06/16

Who/When to Treat Clinically Suspect Arthralgia Thoughtful, Effective RA Care Should be Guided by Need —Not Age The Impact of Biologics on Methotrexate Adherence Jokes Aside: The Impact of Laughter in RA JAK Safety Update Why is RA Difficult to Treat? DMARD Combinations in RA Treatment Increased Risk of VTE in RA: Lessons Learned from 40 Years of Data ALTO: Long-term Outcomes of APIPPRA

en

31:33

EULAR2025 Topic Podcast SpA

Rheumnow Podcast ·

2025/06/16

Efficacy and Safety of Xeligekimab in AS Lessons on Uveitis and AxSpA Difficult to Treat Axial Spondyloarthritis MRI Lesions in Early axSpA vs Non-axSpA Emerging Therapies in Axial Spondyloarthritis Chronic Pain in AxSpA Beyond Fibromyalgia Novel Therapies in Axial Spondyloarthritis GLP 1 Receptor Agonists in axSpA Patients

en

26:02

EULAR2025 Topic Podcast PsA 2

Rheumnow Podcast ·

2025/06/16

Difficult to Treat Psoriatic Arthritis Less or more frequent dosing in PsA? Complex-to-Manage PsA: The GRAPPA Framework and Definition Biologic Switching in PsA Decoding Difficult to Treat PsA Deucravacitinib in Psoriatic Arthritis: A New Oral Option with Dual Impact

en

22:25

EULAR2025 Topic Podcast PsA 1

Rheumnow Podcast ·

2025/06/16

EULAR 2025 - Day 1 podcasts Sonelokimab in PsA Seronegative Arthritis Breakthroughs Using Combination csDMARDs in PsA Deucravacitinib's Place in the PsA Treatment Algorithm?

en

28:38

EULAR 2025 - Day 5 podcast

Rheumnow Podcast ·

2025/06/16

Biologic Switching in PsA Decoding Difficult to Treat PsA Deucravacitinib in Psoriatic Arthritis: A New Oral Option with Dual Impact GLP 1 Receptor Agonists in axSpA Patients Jekyll and Hyde: which RA-ILD is it? RA treatment: A Constant State of Evolution

en

51:35

EULAR 2025 - Day 4 podcast

Rheumnow Podcast ·

2025/06/15

Difficult to Treat Psoriatic ArthritisLess or more frequent dosing in PsA? Complex-to-Manage PsA: The GRAPPA Framework and Definition Emerging Therapies in Axial Spondyloarthritis Chronic Pain in AxSpA Beyond Fibromyalgia Novel Therapies in Axial Spondyloarthritis JAK Inhibitors: The Latest from the JAK-pot Study Does Abatacept Buy You Time Off RA? How to Properly Use Steroids in Early RA: Oral vs Parenteral All Rheumatoid Arthritis is Not the Same

en

40:02

Daily Eular 2025 Recap Day 4

Rheumnow Podcast ·

2025/06/14

Catch up on the biggest breakthroughs, standout sessions, and expert insights from the fourth day of EULAR 2025. Join us live as we break down the key highlights and what they mean for the future of rheumatology.

en

48:01

EULAR 2025 - Day 3 podcast

Rheumnow Podcast ·

2025/06/14

Deucravacitinib's Place in the PsA Treatment Algorithm? Lessons on Uveitis and AxSpA Difficult to Treat Axial Spondyloarthritis MRI Lesions in Early axSpA vs Non-axSpA JAK Safety Update Why is RA Difficult to Treat? DMARD Combinations in RA Treatment Increased Risk of VTE in RA: Lessons Learned from 40 Years of Data ALTO: Long-term Outcomes of APIPPRA

en

36:31

Daily Eular 2025 Recap Day 3

Rheumnow Podcast ·

2025/06/13

Catch up on the biggest breakthroughs, standout sessions, and expert insights from the third day of EULAR 2025. Join us live as we break down the key highlights and what they mean for the future of rheumatology.

en

1,076 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown